Cost burden of post-transplant lymphoproliferative disease following kidney transplants in Medicare-eligible patients by survival status-Reference-Cited by-同舟云学术

Cost burden of post-transplant lymphoproliferative disease following kidney transplants in Medicare-eligible patients by survival status

Published:2021-01-01 Issue:1 Volume:24 Page:620-627
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Hart Allyson¹²^ORCID,Ahn Yoon Son²,Watson Crystal³^ORCID,Skeans Melissa²,Barlev Arie³,Thompson Bryn²,Dharnidharka Vikas R.⁴^ORCID

Affiliation:

1. Division of Nephrology, Hennepin Healthcare, Minneapolis, MN, USA

2. Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, MN, USA

3. Atara Biotherapeutics, South San Francisco, CA, USA

4. St. Louis Children’s Hospital, Washington University School of Medicine, St. Louis, MO, USA

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.1915793

Reference27 articles.

1. National Organisation for Rare Disorders. Post-transplant lymphoproliferative disease 2018. [cited 2020 October]. Available from: https://rarediseases.org/rare-diseases/posttransplant-lymphoproliferative-disorders/

2. Incidence, Risk Factors, Clinical Management, and Outcomes of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients

3. Pharmacovigilance of medicines for rare and ultrarare diseases

4. Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Admissions for posttransplant lymphoproliferative disorder: a 9-year longitudinal analysis of the National (Nationwide) Inpatient Sample;Baylor University Medical Center Proceedings;2024-07-11

2. Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type;Transplantation Reviews;2024-04

3. Short-term decreased post transplant lymphoproliferative disorder risk after kidney transplantation using two novel regimens;Transplant Immunology;2023-02